Loading...

Yu Run

TitleHealth Sciences Clinical Associate Professor
InstitutionUniversity of California Los Angeles
DepartmentEndocrinology Diabetes and Hypertension
Address200 Medical Plaza #530
Los Angeles CA 90095
Phone310-825-7922
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Yu R. INTERPRETATION OF UNEXPECTEDLY HIGH LEVELS OF ENDOCRINE TUMOR MARKERS. Endocr Pract. 2018 Aug 14. PMID: 30106635.
      View in: PubMed
    2. Yu R. Right Atrial Tumor Thrombus: A New Mechanism for Neuroendocrine Tumor-Induced Heart Complications. Pancreas. 2018 May/Jun; 47(5):e26-e27. PMID: 29702532.
      View in: PubMed
    3. Yu R. Mahvash Disease: 10 Years After Discovery. Pancreas. 2018 May/Jun; 47(5):511-515. PMID: 29702528.
      View in: PubMed
    4. Shim J, Rao J, Yu R. Spontaneous Regression of Metastatic Papillary Thyroid Cancer in a Lymph Node. Case Rep Endocrinol. 2018; 2018:5873897. PMID: 29755799.
      View in: PubMed
    5. Yu R. GOITER AS A RED HERRING IN THE TRIAD OF OBESITY, NECK COMPRESSIVE SYMPTOMS, AND GOITER. Endocr Pract. 2018 Mar 02. PMID: 29498918.
      View in: PubMed
    6. Yu R. Concurrent PTHrp- and calcitriol-mediated hypercalcemia associated with cholangiocarcinoma. Endocrinol Diabetes Nutr. 2018 04; 65(4):241-243. PMID: 29366826.
      View in: PubMed
    7. Yang G, Dhall D, Yu R, Tuli R, Amersi FF, Friedman ML, Nissen NN, Hendifar AE. The Clinicopathological Aspects of Primary Presacral Neuroendocrine Neoplasms: One Center Experience. Pancreas. 2018 Jan; 47(1):122-129. PMID: 29215535.
      View in: PubMed
    8. Yu R. VISUAL VIGNETTE. Endocr Pract. 2018 Mar; 24(3):317. PMID: 29144800.
      View in: PubMed
    9. Yu R. Proteasome Inhibitors: A Potential Medical Therapy for Malignant Pheochromocytoma. Endocrinology. 2017 10 01; 158(10):3083-3085. PMID: 28977615.
      View in: PubMed
    10. Yu R, Wachsman A. Imaging of Neuroendocrine Tumors: Indications, Interpretations, Limits, and Pitfalls. Endocrinol Metab Clin North Am. 2017 Sep; 46(3):795-814. PMID: 28760239.
      View in: PubMed
    11. Yu R, Sharaga D, Donner C, Palma Diaz MF, Livhits MJ, Yeh MW. Pheochromocytomatosis associated with a novel TMEM127 mutation. Endocrinol Diabetes Metab Case Rep. 2017; 2017. PMID: 28567294.
      View in: PubMed
    12. Song YL, Yu R, Qiao XW, Bai CM, Lu CM, Xiao Y, Zhong DR, Chen J, Zhao YP, Zhang TP, Song TT, Gao HL, Wan YH, Shen L, Chen J, Lv B, Hao JJ, Zhang Y, Tang L, Chen YJ. Prognostic relevance of UCH-L1 and a-internexin in pancreatic neuroendocrine tumors. Sci Rep. 2017 May 19; 7(1):2205. PMID: 28526880.
      View in: PubMed
    13. Yu R. A thyroid nodule overtreated twice. Endocrinol Diabetes Nutr. 2017 Aug - Sep; 64(7):396-397. PMID: 28968220.
      View in: PubMed
    14. Yu R, Quon A, Hecht JR. VISUAL VIGNETTE. Endocr Pract. 2017 Oct; 23(10):1276. PMID: 28332878.
      View in: PubMed
    15. Yu R, Nissen NN, Hendifar A, Tang L, Song YL, Chen YJ, Fan X. A Clinicopathological Study of Malignant Insulinoma in a Contemporary Series. Pancreas. 2017 01; 46(1):48-56. PMID: 27984486.
      View in: PubMed
    16. Yu R. Visual Vignette. Endocr Pract. 2017 Jul; 23(7):890. PMID: 27967222.
      View in: PubMed
    17. Yu R. Hypercalcemic crisis associated with anastrozole use in a patient with breast cancer and primary hyperparathyroidism. Endocrine. 2016 Sep; 53(3):868-9. PMID: 27369187.
      View in: PubMed
    18. Yu R, Fan X, Bannykh SI. Complete pituitary infarction associated with hypothermia and brain death. Endocrinol Nutr. 2016 May; 63(5):250-2. PMID: 26971812.
      View in: PubMed
    19. Yu R, Wachsman A. VISUAL VIGNETTE. Endocr Pract. 2016 08; 22(8):1027. PMID: 26919646.
      View in: PubMed
    20. Zhu LM, Tang L, Qiao XW, Wolin E, Nissen NN, Dhall D, Chen J, Shen L, Chi Y, Yuan YZ, Ben QW, Lv B, Zhou YR, Bai CM, Chen J, Song YL, Song TT, Lu CM, Yu R, Chen YJ. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study. Medicine (Baltimore). 2016 Feb; 95(7):e2836. PMID: 26886644; PMCID: PMC4998644.
    21. Yu R, Zheng Y, Lucas MB, Tong YG. Elusive liver factor that causes pancreatic a cell hyperplasia: A review of literature. World J Gastrointest Pathophysiol. 2015 Nov 15; 6(4):131-9. PMID: 26600971; PMCID: PMC4644877.
    22. Yu R, Wachsman A, Nissen NN. Visual Vignette. Endocr Pract. 2016 Jan; 22(1):117. PMID: 26523629.
      View in: PubMed
    23. Yu R. Animal models of spontaneous pancreatic neuroendocrine tumors. Mol Cell Endocrinol. 2016 Feb 05; 421:60-7. PMID: 26261055.
      View in: PubMed
    24. Yu R, Wei M, Fan X, Ellis RR, Braunstein GD. Black adrenal adenoma causing Cushing's syndrome: 40 years ago and today. Endocrinol Nutr. 2015 Nov; 62(9):466-9. PMID: 26088906.
      View in: PubMed
    25. Santhanam P, Chandramahanti S, Kroiss A, Yu R, Ruszniewski P, Kumar R, Taïeb D. Nuclear imaging of neuroendocrine tumors with unknown primary: why, when and how? Eur J Nucl Med Mol Imaging. 2015 Jun; 42(7):1144-55. PMID: 25771906.
      View in: PubMed
    26. Dow A, Russell RV, Bonert V, Carmichael J, Mamelak A, Pressman BD, Fan X, Yu R. A protracted and aggressive variant of lymphocytic hypophysitis with mammillary body involvement and cognitive dysfunction. Endocr Pract. 2014 Nov; 20(11):e225-9. PMID: 25100390.
      View in: PubMed
    27. Wei M, Yu R, Deutsch SC. Insignificant medium-term vitamin D status change after 25-hydroxyvitamin D testing in a large managed care population. PLoS One. 2014; 9(8):e105571. PMID: 25136806; PMCID: PMC4138213.
    28. Yu R, Wei M. Seasonal variations of plasma normetanephrine levels in Los Angeles. Eur J Endocrinol. 2014 May; 170(5):L1-2. PMID: 24723668.
      View in: PubMed
    29. Yu R. Commentary on "Surge in US outpatient vitamin D deficiency diagnoses: National Ambulatory Medical Care Survey analysis". South Med J. 2014 Apr; 107(4):218-9. PMID: 24937513.
      View in: PubMed
    30. Liu B, Tang LH, Liu Z, Mei M, Yu R, Dhall D, Qiao XW, Zhang TP, Zhao YP, Liu TH, Xiao Y, Chen J, Xiang HD, Wu HY, Lu CM, Lv B, Zhou YR, Zhang Y, Deng D, Chen YJ. a-Internexin: a novel biomarker for pancreatic neuroendocrine tumor aggressiveness. J Clin Endocrinol Metab. 2014 May; 99(5):E786-95. PMID: 24483152.
      View in: PubMed
    31. Yu R, Nissen NN, Dhall D. Exocrine pancreas hyperplasia without dysplasia in glucagon receptor knockout mice. Pancreas. 2014 Jan; 43(1):143-5. PMID: 24326371.
      View in: PubMed
    32. Yu VE, Yu R. Visual vignette. Endocr Pract. 2014 Jan; 20(1):97. PMID: 24126233.
      View in: PubMed
    33. Yu R. Pancreatic a-cell hyperplasia: facts and myths. J Clin Endocrinol Metab. 2014 Mar; 99(3):748-56. PMID: 24285676.
      View in: PubMed
    34. Dow A, Yu R, Carmichael J. Too little or too much corticosteroid? Coexisting adrenal insufficiency and Cushing's syndrome from chronic, intermittent use of intranasal betamethasone. Endocrinol Diabetes Metab Case Rep. 2013; 2013:130036. PMID: 24616769; PMCID: PMC3922114.
    35. Pitts A, Nissen NN, Waxman A, Yu R. Unsuspected fluorodeoxyglucose positron emission tomography (FDG-PET)-positive pancreatic lesions: prevalence and significance. Pancreas. 2013 Oct; 42(7):1191-3. PMID: 24048460.
      View in: PubMed
    36. Babu V, Paul N, Yu R. Animal models and cell lines of pancreatic neuroendocrine tumors. Pancreas. 2013 Aug; 42(6):912-23. PMID: 23851429.
      View in: PubMed
    37. Pitts A, Ih G, Wei M, Dhall D, Nissen NN, Waxman A, Yu R. Clinical utility of FDG-PET for diagnosis of adrenal mass: a large single-center experience. Hormones (Athens). 2013 Jul-Sep; 12(3):417-27. PMID: 24121383.
      View in: PubMed
    38. Yu R, Jih L, Zhai J, Nissen NN, Colquhoun S, Wolin E, Dhall D. Mixed acinar-endocrine carcinoma of the pancreas: new clinical and pathological features in a contemporary series. Pancreas. 2013 Apr; 42(3):429-35. PMID: 23462323.
      View in: PubMed
    39. Yu R. Hypercalcemia: from a rainy city to a sunny desert. Endocrinol Nutr. 2013 Nov; 60(9):e27-9. PMID: 23538278.
      View in: PubMed
    40. Ozao-Choy J, Friedman ML, Kim AS, Wachsman A, Wolin EM, Yu R, Nissen NN, Colquhoun SD. Radioembolization for treatment of liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers. Pancreas. 2013 Mar; 42(2):358-60. PMID: 23407486.
      View in: PubMed
    41. Al-Sarireh B, Haidermota M, Verbeke C, Rees DA, Yu R, Griffiths AP. Glucagon cell adenomatosis without glucagon receptor mutation. Pancreas. 2013 Mar; 42(2):360-2. PMID: 23407487.
      View in: PubMed
    42. Milanesi A, Yu R, Wolin EM. Humoral hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting neuroendocrine tumors. Report of six cases. Pancreatology. 2013 May-Jun; 13(3):324-6. PMID: 23719609.
      View in: PubMed
    43. Ro C, Chai W, Yu VE, Yu R. Pancreatic neuroendocrine tumors: biology, diagnosis,and treatment. Chin J Cancer. 2013 Jun; 32(6):312-24. PMID: 23237225; PMCID: PMC3845620.
    44. Yu R, Wolin E. Ghost carcinoid in a patient with 120-fold elevated 5-hydroxyindoacetic acid. Endocr Pract. 2012 Sep-Oct; 18(5):803-4. PMID: 23047932.
      View in: PubMed
    45. Zalom M, Yu R, Friedman M, Bresee C, Waxman A. FDG PET/CT as a prognostic test after 90Y radioembolization in patients with metastatic hepatic disease. Clin Nucl Med. 2012 Sep; 37(9):862-5. PMID: 22889775.
      View in: PubMed
    46. Yu R, Ren SG, Mirocha J. Glucagon receptor is required for long-term survival: a natural history study of the Mahvash disease in a murine model. Endocrinol Nutr. 2012 Nov; 59(9):523-30. PMID: 22951296.
      View in: PubMed
    47. Yu R, Phillips E. Growth speed of sporadic pheochromocytoma. Clin Endocrinol (Oxf). 2012 Aug; 77(2):331-2. PMID: 22243126.
      View in: PubMed
    48. Yu R, Nissen NN, Bannykh SI. Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors. Endocr Pract. 2012 Jul-Aug; 18(4):483-92. PMID: 22297057.
      View in: PubMed
    49. Yu R, Bannykh SI, Marchevsky A. Cardiac arrest in a patient with asthma: role of hemorrhagic pheochromocytoma discovered at autopsy. J Clin Hypertens (Greenwich). 2012 Sep; 14(9):650-2. PMID: 22947365.
      View in: PubMed
    50. Yu R, Nissen NN, Balzer B, Fan X. Novel syndrome of four-limb proximal fragility fractures associated with HIV infection, cholestatic liver failure, and histiocytic infiltration of bone marrow. Hormones (Athens). 2012 Apr-Jun; 11(2):203-6. PMID: 22801567.
      View in: PubMed
    51. Yu R, Pitts A, Wei M. Small pheochromocytomas: significance, diagnosis, and outcome. J Clin Hypertens (Greenwich). 2012 May; 14(5):307-15. PMID: 22533657.
      View in: PubMed
    52. Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, Yu R, Nissen NN, Wolin E. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol. 2012 Apr; 43(4):489-95. PMID: 21937080.
      View in: PubMed
    53. Milanesi A, Azer P, Yu R. Internal jugular thrombus revealed by fine-needle aspiration to be metastatic papillary thyroid carcinoma. Endocr Pract. 2011 Sep-Oct; 17(5):827-8. PMID: 22081830.
      View in: PubMed
    54. Yu R, Dhall D, Nissen NN, Zhou C, Ren SG. Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice. PLoS One. 2011; 6(8):e23397. PMID: 21853126; PMCID: PMC3154424.
    55. Milanesi A, Dhall D, Yu R. Adrenal Cushing syndrome shortly after adrenal insufficiency. Endocr Pract. 2011 Jul-Aug; 17(4):656-7. PMID: 21846621.
      View in: PubMed
    56. Yu R, Wawrowsky K, Zhou C. A natural inactivating mutant of human glucagon receptor exhibits multiple abnormalities in processing and signaling. Endocrinol Nutr. 2011 Jun-Jul; 58(6):258-66. PMID: 21680267.
      View in: PubMed
    57. Yu R, Nissen NN, Dhall D, Phillips E. Diagnosis and management of pheochromocytoma in an academic hospital 3 years after formation of a pheochromocytoma interest group. Endocr Pract. 2011 May-Jun; 17(3):356-62. PMID: 21134876.
      View in: PubMed
    58. Milanesi A, Yu R, Geller SA, Burton D, Deftos LJ, Wolin EM. Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1. Pancreas. 2011 May; 40(4):634-7. PMID: 21483254.
      View in: PubMed
    59. Milanesi A, Ho A, Ewing A, Yu R. Bilateral pheochromocytoma manifesting as acute shortness of breath after job loss. Endocr Pract. 2011 Mar-Apr; 17(2):307-8. PMID: 21612018.
      View in: PubMed
    60. Ouyang D, Dhall D, Yu R. Pathologic pancreatic endocrine cell hyperplasia. World J Gastroenterol. 2011 Jan 14; 17(2):137-43. PMID: 21245985; PMCID: PMC3020366.
    61. Yu R, Wolin E, Fan X. Single Subcutaneous Nodule as Initial Presentation of Atypical Lung Carcinoid. World J Oncol. 2010 Oct; 1(5):204-207. PMID: 29147207.
      View in: PubMed
    62. Nalawadi SS, Siegel RJ, Wolin E, Yu R, Trento A, Shiota T, Tolstrup K, Luthringer D, Gurudevan S. Morphologic features of carcinoid heart disease as assessed by three-dimensional transesophageal echocardiography. Echocardiography. 2010 Oct; 27(9):1098-105. PMID: 21039812.
      View in: PubMed
    63. Lev I, Kelekar G, Waxman A, Yu R. Clinical use and utility of metaiodobenzylguanidine scintigraphy in pheochromocytoma diagnosis. Endocr Pract. 2010 May-Jun; 16(3):398-407. PMID: 20061293.
      View in: PubMed
    64. Milanesi A, Wolin E, Wachsman A, Yu R. Spared adrenals: transient florid ectopic Cushing syndrome associated with necrosis of metastatic carcinoid. Endocr Pract. 2010 May-Jun; 16(3):527-8. PMID: 20564793.
      View in: PubMed
    65. Yu R, Melmed S. Pathogenesis of pituitary tumors. Prog Brain Res. 2010; 182:207-27. PMID: 20541667.
      View in: PubMed
    66. Buchbinder NA, Yu R, Rosenbloom BE, Sherman CT, Silberman AW. Left ventricular thrombus and embolic stroke caused by a functional paraganglioma. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):734-7. PMID: 20021531.
      View in: PubMed
    67. Zhou C, Dhall D, Nissen NN, Chen CR, Yu R. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas. 2009 Nov; 38(8):941-6. PMID: 19657311; PMCID: PMC2767399.
    68. Nissen NN, Kim AS, Yu R, Wolin EM, Friedman ML, Lo SK, Wachsman AM, Colquhoun SD. Pancreatic neuroendocrine tumors: presentation, management, and outcomes. Am Surg. 2009 Oct; 75(10):1025-9. PMID: 19886158.
      View in: PubMed
    69. Zalom ML, Waxman AD, Yu R, Lee J, Ih G, Wolin EM. Metabolic and receptor imaging in patients with neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium in 111 pentetreotide. Endocr Pract. 2009 Sep-Oct; 15(6):521-7. PMID: 19491080.
      View in: PubMed
    70. Yu R. Ordering pattern and performance of biochemical tests for diagnosing pheochromocytoma between 2000 and 2008. Endocr Pract. 2009 May-Jun; 15(4):313-21. PMID: 19502210.
      View in: PubMed
    71. Chesnokova V, Wong C, Zonis S, Gruszka A, Wawrowsky K, Ren SG, Benshlomo A, Yu R. Diminished pancreatic beta-cell mass in securin-null mice is caused by beta-cell apoptosis and senescence. Endocrinology. 2009 Jun; 150(6):2603-10. PMID: 19213844; PMCID: PMC2689808.
    72. Yu R, Nissen NN, Chopra P, Dhall D, Phillips E, Wei M. Diagnosis and treatment of pheochromocytoma in an academic hospital from 1997 to 2007. Am J Med. 2009 Jan; 122(1):85-95. PMID: 19114176.
      View in: PubMed
    73. Yu R, Furmark L, Wong C. Cardiac abnormalities associated with pheochromocytoma and other adrenal tumors. Endocr Pract. 2009 Jan-Feb; 15(1):10-6. PMID: 19211391.
      View in: PubMed
    74. Yu R, Nissen NN, Dhall D, Wei M. Pheochromocytoma in patients suspected of harboring adrenal metastasis: management and clinical predictors. Endocr Pract. 2008 Nov; 14(8):967-72. PMID: 19095594.
      View in: PubMed
    75. Yu R, Nissen NN, Dhall D, Heaney AP. Nesidioblastosis and hyperplasia of alpha cells, microglucagonoma, and nonfunctioning islet cell tumor of the pancreas: review of the literature. Pancreas. 2008 May; 36(4):428-31. PMID: 18437091.
      View in: PubMed
    76. Yu R, Ginsburg E. Natural history of a sporadic pheochromocytoma. Endocr Pract. 2008 Apr; 14(3):391. PMID: 18463050.
      View in: PubMed
    77. Melmed GY, Devlin SM, Vlotides G, Dhall D, Ross S, Yu R, Melmed S. Anti-aging therapy with human growth hormone associated with metastatic colon cancer in a patient with Crohn's colitis. Clin Gastroenterol Hepatol. 2008 Mar; 6(3):360-3. PMID: 18255351; PMCID: PMC2696478.
    78. Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K, Melmed S. Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth. Cancer Res. 2007 Nov 01; 67(21):10564-72. PMID: 17975001; PMCID: PMC2770267.
    79. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. J Clin Endocrinol Metab. 2006 Dec; 91(12):5126-9. PMID: 17018653.
      View in: PubMed
    80. Yu R, Cruz-Soto M, Li Calzi S, Hui H, Melmed S. Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells. J Endocrinol. 2006 Oct; 191(1):45-53. PMID: 17065388.
      View in: PubMed
    81. Yu R, Bonert V, Cruz-Soto M, Melmed S. Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism. Endocrine. 2006 Feb; 29(1):119-20. PMID: 16622299.
      View in: PubMed
    82. Liu G, Shi F, Blas-Machado U, Yu R, Davis VL, Foster WG, Magoffin DA, Hughes CL. Dietary galactose inhibits GDF-9 mediated follicular development in the rat ovary. Reprod Toxicol. 2006 Jan; 21(1):26-33. PMID: 16105726.
      View in: PubMed
    83. Akino K, Akita S, Mizuguchi T, Takumi I, Yu R, Wang XY, Rozga J, Demetriou AA, Melmed S, Ohtsuru A, Yamashita S. A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration. J Surg Res. 2005 Nov; 129(1):142-6. PMID: 15936773.
      View in: PubMed
    84. Yu R, Melmed S. Pituitary tumor transforming gene: an update. Front Horm Res. 2004; 32:175-85. PMID: 15281346.
      View in: PubMed
    85. Ren SG, Taylor J, Dong J, Yu R, Culler MD, Melmed S. Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab. 2003 Sep; 88(9):4239-45. PMID: 12970293.
      View in: PubMed
    86. Rubinek T, Yu R, Hadani M, Barkai G, Nass D, Melmed S, Shimon I. The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion. J Clin Endocrinol Metab. 2003 Aug; 88(8):3724-30. PMID: 12915661.
      View in: PubMed
    87. Yu R, Lu W, Chen J, McCabe CJ, Melmed S. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology. 2003 Nov; 144(11):4991-8. PMID: 12960092.
      View in: PubMed
    88. Wang Z, Moro E, Kovacs K, Yu R, Melmed S. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci U S A. 2003 Mar 18; 100(6):3428-32. PMID: 12626748; PMCID: PMC152309.
    89. Hui H, Yu R, Bousquet C, Perfetti R. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion. Endocrinology. 2002 Sep; 143(9):3529-39. PMID: 12193567.
      View in: PubMed